Merck & Co., Inc.

Q: How do I trade MRK on Bybit?

Click the Trade button above to explore available products for Merck & Co., Inc. on Bybit, including Stocks (real equity), Perpetuals (leveraged, 24/7), xStocks (wallet-based, 24/7), and CFDs. Each suits a different trading strategy. Product availability may vary.

Q: Does Merck & Co., Inc. pay dividends?

Merck & Co., Inc.'s current dividend yield is shown in the Key Metrics section. Bybit Stocks holders receive dividend distributions when declared, while Perpetual holders receive equivalent adjustments via the funding rate.

Q: What is Merck & Co., Inc.'s P/E ratio, and what does it mean?

Merck & Co., Inc.'s P/E ratio is shown in the Key Metrics section, along with its percentile ranking relative to peers in the Pharmaceuticals sector. A higher P/E typically reflects higher growth expectations, while a lower P/E may indicate undervaluation.

Q: What financial results has Merck & Co., Inc. recently released?

The most recent quarterly results, including revenue, operating income, and net profit, are shown in the Financials section. Historical trends are available via the interactive charts.

Q: Can I trade MRK 24/7 on Bybit?

{{ticker}} Perpetuals and xStocks are available for 24/7 trading. Stocks trading follows regular market hours, with limited pre-market and post-market sessions.

Q: What payment methods can I use to buy MRK?

You can fund your Bybit account by depositing crypto, including USDT, or using a credit/debit card. Stocks, Perpetuals, and CFDs are all settled in USDT.

Q: How does buying MRK on Bybit compare to using a traditional broker?

If Stocks trading is available for Merck & Co., Inc., Bybit gives you direct equity ownership, including dividend eligibility, similar to a traditional broker. Bybit also offers leveraged derivative products, including Perpetuals and CFDs, as well as tokenized products such as xStocks, all in a single account.

MRK

www.merck.com

Pharmaceuticals

1m5m15m1h4h1d1w

About Merck & Co., Inc.

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a...

IndustryPharmaceuticalsHeadquarters126 EAST LINCOLN AVENUE, RAHWAY, NJPrimary ExchangeNYSEEmployees75,000Listing DateApr 20, 1949Websitewww.merck.com

Key Metrics

$362.35B

114.2x

8.6x

$1.15B

-$0.54

7.57%

2.44%

2.29%

Corporate Actions

Earnings ReportSep 30, 2024

FY2024 Q3 earnings reported. Diluted EPS: $1.24.

Ex-DividendDec 16, 2024

Quarterly dividend of $0.81 per share. Ex-dividend date: December 16. Payable: January 8.

Earnings ReportDec 31, 2024

FY2024 Q4 earnings reported. Diluted EPS: $1.48.

Earnings ReportDec 31, 2024

FY2024 Q4 earnings reported. Diluted EPS: $6.74.

Ex-DividendMar 17, 2025

Quarterly dividend of $0.81 per share. Ex-dividend date: March 17. Payable: April 7.

Earnings ReportMar 31, 2025

FY2025 Q1 earnings reported. Diluted EPS: $2.01.

Ex-DividendJun 16, 2025

Quarterly dividend of $0.81 per share. Ex-dividend date: June 16. Payable: July 8.

Earnings ReportJun 30, 2025

FY2025 Q2 earnings reported. Diluted EPS: $1.76.

Ex-DividendSep 15, 2025

Quarterly dividend of $0.81 per share. Ex-dividend date: September 15. Payable: October 7.

Earnings ReportSep 30, 2025

FY2025 Q3 earnings reported. Diluted EPS: $2.32.

Ex-DividendDec 15, 2025

Quarterly dividend of $0.85 per share. Ex-dividend date: December 15. Payable: January 8.

Earnings ReportDec 31, 2025

FY2025 Q4 earnings reported. Diluted EPS: $7.28.

Earnings ReportDec 31, 2025

FY2025 Q4 earnings reported. Diluted EPS: $1.19.

Ex-DividendMar 16, 2026

Quarterly dividend of $0.85 per share. Ex-dividend date: March 16. Payable: April 7.

Earnings ReportMar 31, 2026

FY2026 Q1 earnings reported. Diluted EPS: -$1.72.

Ex-DividendJun 15, 2026

Quarterly dividend of $0.85 per share. Ex-dividend date: June 15. Payable: July 8.

Earnings ReportJun 30, 2026

FY2026 Q2 earnings reported. Diluted EPS: -$0.54.

Ex-DividendSep 15, 2026

Quarterly dividend of $0.85 per share. Ex-dividend date: September 15. Payable: October 7.

FAQ about Merck & Co., Inc.

What is the current price of Merck & Co., Inc.?

›

The current price of MRK is shown in the price section above and updated in real time during regular trading hours. If you trade MRK Perpetuals on Bybit, pre-market, post-market, and overnight prices are also available.

How do I trade MRK on Bybit?

›

Does Merck & Co., Inc. pay dividends?

›

What is Merck & Co., Inc.'s P/E ratio, and what does it mean?

›

What financial results has Merck & Co., Inc. recently released?

›

Can I trade MRK 24/7 on Bybit?

›

What payment methods can I use to buy MRK?

›

How does buying MRK on Bybit compare to using a traditional broker?

›

Disclaimer

The information contained herein is provided for informational purposes only and does not constitute investment, financial, trading, or other professional advice. Trading in digital assets and securities involves substantial risk of loss, including the possible loss of all principal invested. The value of digital assets and securities may be highly volatile, and past performance is not indicative of future results. Market data displayed is sourced from third-party data providers and may be subject to delays or inaccuracies. Bybit does not warrant the accuracy, completeness, or timeliness of any information displayed. All investment decisions are made solely at the investor's own risk. Independent due diligence and consultation with a licensed financial advisor are strongly recommended before making any investment decision.

Trade MRK

US Dollar: Oil-driven support as Fed seen hiking – ING

Financia lJuice1h ago

Experts agree: Further US Dollar’s upside hinges on upcoming data and not hawkish Fed prospects

Financia lJuice2h ago

Federal Reserve's Goolsbee: If there is solid evidence that inflation is coming back down to 2%, I have no objection to rate cuts

PANews2h ago

Gold: Range-bound outlook with Fed headwinds – ING

Financia lJuice3h ago

Gold starts the week on the back foot as the US Dollar holds firm, oil decline limits losses.